Cargando…
Clinical Pharmacology of Insulin Aspart Biosimilar GP40071: Pharmacokinetic/Pharmacodynamic Comparability in Hyperinsulinemic Euglycemic Clamp Procedure
Insulin aspart is a short‐acting insulin analogue that is used to control postprandial glycemia levels in diabetic patients. The aim of this clinical trial was to compare the pharmacokinetics and pharmacodynamics of GP40071 (GP‐Asp) and NovoRapid Penfill (Novo‐Asp) in a hyperinsulinemic euglycemic c...
Autores principales: | Drai, Roman V., Karonova, Tatiana L., Mayorov, Alexander Y., Makarenko, Igor E., Dorotenko, Artem R., Kulesh, Viktoria S., Kovalik, Vladislav V., Andreeva, Alena T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9541865/ https://www.ncbi.nlm.nih.gov/pubmed/35230749 http://dx.doi.org/10.1002/cpdd.1084 |
Ejemplares similares
-
A mathematical model of the euglycemic hyperinsulinemic clamp
por: Picchini, Umberto, et al.
Publicado: (2005) -
Hyperinsulinemic-euglycemic Clamps in Conscious, Unrestrained Mice
por: Ayala, Julio E., et al.
Publicado: (2011) -
Defining Insulin Resistance From Hyperinsulinemic-Euglycemic Clamps
por: Tam, Charmaine S., et al.
Publicado: (2012) -
A randomized, double‐blind, comparative study of the pharmacodynamics and pharmacokinetics of GP40141 (romiplostim biosimilar) and reference romiplostim in healthy male volunteers
por: Makarenko, Igor, et al.
Publicado: (2023) -
Presence of Myeloperoxidase in Lamellar Tissue of Horses Induced by an Euglycemic Hyperinsulinemic Clamp
por: Storms, Nazare, et al.
Publicado: (2022)